Role of NK cells and invariant NKT cells in multiple sclerosis

Results and Problems in Cell Differentiation

Volumn 51, Issue , 2010, Pages 127-147

  Sakuishi, Kaori ^a   Miyake, Sachiko ^a   Yamamura, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; MR1 PROTEIN, HUMAN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MICE; MODELS, IMMUNOLOGICAL; MULTIPLE SCLEROSIS; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 77956910496     PISSN: 00801844     EISSN: 18610412     Source Type: Book Series    
DOI: 10.1007/400_2009_11     Document Type: Article

References (115)

1. Araki M, Kondo T, Gumperz J, Brenner M, Miyake S, Yamamura T (2003) Th 2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol 15:279-288
2. Araki M, Miyake S, Yamamura T (2004) Continuous oral glucocorticoid therapy restores the NKT cell frequency in multiple sclerosis. Neuroimmunology 12:175-179
3. Aranami T, Miyake S, Takahashi K (2006) Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple slcerosis. J Immunol 177:5659-5667
4. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8:1380-1389
5. Backstrom E, Ljunggren H, Kristensson K (2007) NK cell-mediated destruction of influenza A virus-infected peripheral but not central neurons. Scand J Immunol 65:353-361
6. Baecher-Allan C, Hafler D (2006) Human regulatory T cells and their role in autoimmune disease. Immunol Rev 212:203-216
7. Ballas Z, Rasmussen W (1990) NK1.1+ thymocytes, adult murine CD4-CD8thymocytes contain an NK1.1+, CD3+, CD5+, CD44+, TCR-Vb 8+ subset. J Immunol 145:1039-1045
8. Benczur M, Petranyl G, Palffy G, Varga M, Talas M, Kotsy B, et al. (1980) Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor. Clin Exp Immunol 39:657-662
9. Bendelac A, Fearon DT (1997) Innate pathways that control acquired immunity. Curr Opin Immunol 9:1-3
10. Bendelac A, Savage P, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297-336
11. Bielekova B, Goodwin B, Richert J, Cortese I, Kondo T, Afshar G (2000) Encephalitogenic potential of the myelin basic protein peptite (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med 6:1167-1175
12. Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann T, et al. (2006) Regulatory CD56 (bright) natural killer cells mediate immunomodulatory effects of IL-2R-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 103:5941-5946
13. Bilisland C, Diamond M, Springer T (1994) The leukocyte integrin p150, 95 (CD11c/CD18) as a receptor for ic3b: activation by a heterologousβsubunit and localization of a ligand recognition site to the I domain. J Immunol 152:4582-4589
14. Borg N, Wun K, Kjor-Nielson L, Wilce M, Pellicci D, Koh R, et al. (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448:44-49
15. Borrego F, Masilamani M, Marusima A, Tang X, Coligan J (2006) The CD94/NKG2 family of receptors from molecules and cells to clinical relevance. Immnol Res 35:263-294
16. Brigl M, Brenner M (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22:817-890
17. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, et al. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188:1521-1528
18. Carrol M, Prodeus A (1998) Linkages of innate and adaptive immunity. Curr Opin Immunol 10:36-40
19. Correale J, McMillan M, McCarthy K, Le T, Weiner L (1995) Isolation and characterization of autoreactive proteolipid protein-peptide specific T cell clones from multiple sclerosis patients. Neurology 45:1370-1378
20. Croxford J, Miyake S, Huang Y, Shimamura M, Yamamura T (2006) Invariant Vα19i T cells regulate autoimmune inflammation. Nat Immunol 7:987-994
21. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A (1994) An invariant Vα24-JαQ/Vβ11 T cell receptor is expressed in all individual by clonally expanded CD4-CD8-T cells. J Exp Med 180:1171-1176
22. Diefenbach A, Jamieson A, Liu S, Shastri N, Raulet D (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1:119-126
23. Exley M, Garcia J, Balk S, Porcelli S (1997) Requirements for CD1d recognition by human invariant Vβ24+ CD4-CD8-T cells. J Exp Med 186:109-120
24. Exley M, Garcia J, Wilson S, Spada F, Gerdes D, Tahir S, et al. (2000) CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 100:37-47
25. Fearon D, Locksley R (1996) The instructive role of innate immunity in the acquired immune response. Science 272:50-53
26. Fowlkes B, Kruisbeek A, Ton-That H, Weston M, Coligan J, Schwartz R, et al. (1987) A novel population of T-cell receptor aβ-bearing thymocytes which predominantly express a single Vβgene family. Nature 329:251-254
27. Furlan R, Bergami A, Cantarella D, Brambilla E, Taniguchi M, Dellabona P, et al. (2003) Activation of invariant NKT cells by agalcer administration protects mice from MOG 35-55-induced EAE: critical roles for administration route and IFN-γ. Eur J Immunol 33:1830-1838
28. Gigli G, Caielli S, Cutuli D, Falcone M (2007) Innate immunity modulates autoimmunity: type 1 interferon-b treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation. Immunology 122:409-417
29. Goff R, Gao Y, Mattner J, Zhou D, Yin N, Cantu C 3rd, et al. (2004) Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells. J Am Chem Soc 126:13602
30. Goodnow C, Sprent J, Fazekas de St. Groth B, Vinuesa C (2005) Cellular and genetic mechanism of self-tolerance and immunity. Nature 435:590-597
31. Gumperz J, Miyake S, Yamamura T, Brenner M (2002) Functionally distinct subsets of CD1drestricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195:625-636
32. Hafler D (2004) Multiple sclerosis. J Clin Invest 113:788-794
33. Hauser S, Ault K, Levin M, Garovoy M, Weiner H (1981) Natural killer cell activity in multiple sclerosis. J Immunol 127:1114-1117
34. Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van Stipdonk M, et al. (2002) CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16:403-415
35. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, et al. (2001) The natural killer T-cell ligandα-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 7:1052-1056
36. Hoshino T, WInkler-Pickett RT, Mason AT, Ortaldo JR, Young HA (1999) IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-γ. J Immunol 162:51-59
37. Huang D, Shi F, Jung S, Pien G, Wang J, Salazar-Mather T, et al. (2006) The neuronal chemokine CX3CR1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 20:896-905
38. Huseby E, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman JA (2001) Pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis. J Exp Med 194:669-676
39. Iglesias A, Bauer J, Litzenburger T, Schubart A, Linington C (2001) T-and B-Cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36:220-234
40. Illés Z, Kondo T, Yokoyama K, Ohashi T, Tabira T, Yamamura T (1999) Identification of autoimmune T cells among in vivo expanded CD25+ T cells in multiple sclerosis. J Immunol 162:1811-1817
41. Illés Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T (2000) Differential expression of NK Tcell Vβ24 JαQ invariant TCR chain in the lesion of multiple sclerosis and chornic inflammatory demyelinating polyneuropathy. J Immunol 164:4375-4381
42. Illés Z, Shimamura M, Newcombe J, Oka N, Yamamura T (2004) Accumulation of Vα7.2- Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol 16:223-230
43. Infante-Duarte C, Weber A, Kratschmar J, Prozorovski T, Pikol S, Hamann I, et al. (2005) Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis. FASEB J 19:1902-1904
44. Jahng A, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, et al. (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephlomyelitis. J Exp Med 194:1789-1799
45. Kastrukoff L, Morgan N, Zecchini D, White R, Petkau A, Satoh J, et al. (1998) A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J Neuroimmunol 86:123-133
46. Kastrukoff L, Lau A, Wee R, Zecchini D, White R, Paty D (2003) Clinical relapse of multiple sclerosis are associated with novel valleys in natural killer cell functional activity. J Neuroimmunol 145:103-114
47. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, et al. (1997) CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylcermides. Science 278:1626-1629
48. Kim C, Johnston B, Butcher E (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vβ24+Vβ11+ NKT cell subsets with distinct cytokineproducing capacity. Blood 100:11-16
49. Kinjo Y, Wu D, Kim G, Xing G, Poles M, Ho D, et al. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520-525
50. Kirwan S, Burshtyn D (2007) Regulation of natural killer cell activity. Curr Opin Immunol 19:46-54
51. Koehler N, Genain C, Giesser B, Hauser S (2002) The human T cell response to myelin oligodendrocyte glycoprotein: a multiple scleorsis family-based study. J Immunol 168:5920-5927
52. Kondo T, Yamamura T, Inobe J, Ohashi T, Takahashi K, Tabira T (1996) TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences. Int Immunol 8:123-130
53. Koseki H, Asano H, Inaba T, Miyashita N, Moriwaki K, Lindahl K, et al. (1991) Dominant expression of a distinctive V14+ T-cell antigen receptor a chain in mice. Proc Natl Acad Sci U S A 88:7518-7522
54. Kronenberg M (2005) Toward understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005: 877-900
55. Kyewski B, Derbinski J (2004) Self-representation is the thymus: an extended view. Nat Rev Immunol 4:688-698
56. Lee P, Benlagha K, Teyton L, Bendelac A (2002) Distinct functional lineages of human Vβ24 natural killer T cells. J Exp Med 195:637-641
57. Lopez-Botet M, Perez-Villar J, Carretero M, Rodriguez A, Melero I, Bellon T (1997) Structure and function of the CD94 C-type lectin receptor complex involved in the recognition of HLA class I molecules. Immunol Rev 155:165-174
58. Mars L, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, et al. (2002) Cutting edge: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol 168:6007-6011
59. Martin R, Howell M, Jaraquemada D, Flerlage M, Richert J, Brostoff S (1991) A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173:19-24
60. Matsumoto Y, Kohyama K, Aikawa Y, Shin T, Kawazoe Y, Suzuki Y, et al. (1998) Role of natural killer cells and TCRβT cells in acute autoimmune encephalomyelitis. Eur J Immunol 28:1681-1688
61. Mattner J, Debord K, Ismail N, Goff R, Cantu 3rd C, Zhou D, et al. (2005) Exogenous, and endogenous glycolipid antigens activate NKT cells during microbial infection. Nature 434:525-529
62. McCarthy C, Shepherd D, Floire S, Stronge V, Koch M, Illarionov P, et al. (2007) The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 204:1131-1144
63. Medzhitov R, Janeway JC (1997) Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9:4-9
64. Mempel M, Ronet C, Suarez F, Gilleron M, Puzo G, Van Kaer L, et al. (2002) Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J Immunol 168:365-371
65. Mendel I, Kerlero de Rosbo N, Bennun AA (1995) Myeline oligodendrocyte glycoportein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2βmice: fine specificity and T cell receptor Vβexpression of encephalitogenic T ells. Eur J Immunol 25:1951-1959
66. Miyamoto K, Miyake S, Yamamura T (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531-534
67. Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13:108-116
68. Morelli A, Larregina A, Shufesky W, Zahorchak A, Logar A, Papworth G, et al. (2003) Internalization of circulating apoptopic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101:611-620
69. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari M (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197-223
70. Morse RH, Seguin R, McCrea EL, Antel JP (2001) NK cell-mediated lysis of autologous human oligodendrocytes. J Neuroimmunol 116:107-115
71. Munschauer F, Hartrich L, Stewart C, Jacobs L (1995) Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple slcerosis and little clinical disability as compared to controls. J Neuroimmunol 62:177-181
72. Ohashi T, Yamamura T, J-i Inobe, Kondo T, Kunishita T, Tabira T (1990) Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLADR2, w15-associated determinant. Int Immunol 7:1771-1778
73. Oki S, Chiba A, Yamamura T, Miyake S (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest 113:1631-1640
74. Oki S, Tomi C, Yamamura T, Miyake S (2005) Preferential Th 2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokine by bystander cells in vivo. Int Immunol 17:1619-1629
75. Ota K, Matsui M, Milford E, Mackin G, Weiner H, Hafler D (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187
76. Pal E, Tabira T, Kawano T, Taniguchi M, Miyake S, Yamamura T (2001) Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Va14 NK T cells. J Immunol 166:662-668
77. Pelfrey C, Trotter J, Tranquill L, McFarland H (1993) Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. J Neuroimmunol 46:33-42
78. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G (1998) Cutting edge. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161:5821-5824
79. Pette M, Fujita K, Wilkinson D, Altmann D, Trowsdale J, Giegerich G, Wekerle H (1990) Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple slcerosis patients and healthy donors. Proc Natl Acad Sci U S A 87:7968-7972
80. Pillarisetty V, Katz S, Bleier J, Shah A, Dematteo R (2005) Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γvia autocrine IL-12. J Immunol 174:2612-2618
81. Porcelli S, Yockey C, Brenner M, Balk S (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-CD8α/γT cells demonstrates preferential use of several Vγgenes and an invariant TCRa chain. J Exp Med 178:1-16
82. Porubsky S, Speak A, Luckow B, Cerundolo V, Platt F, Grone H (2007) Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci U S A 104:5977-5982
83. Rauch H, Montgomery I, Kaplan J (1985) Natural killer cell activity in multiple sclerosis and myasthenia gravis. Immunol Invest 14:427-434
84. Rice G, Casali P, Merigan T, Oldstone M (1983) Natural killer cell activity in patients with multiple sclerosis given a interferon. Ann Neurol 1983: 333-338
85. Richert J, Robinson E, Deibler G, Martenson R, Dragovic L, Kies M (1989) Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein. Ann Neurol 26:342-346
86. Roncarolo M, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings M (2006) Interleukin-10-secreting type I regulatory T cells in rodents and humans. Immunol Rev 212:28-50
87. Sakuishi K, Oki S, Araki M, Porcelli S, Miyake S, Yamamura T (2007) Invariant NKT cell biased for IL-5 production act as crucial regulators of inflammation. J Immunol 179:3452-3462
88. Santoli D, Hall W, Kastrukoff L, Lisak R, Perussia B, Trinchieri G, et al. (1981) Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol 126:1274-1278
89. Saraste M, Irjala H, Airas L (2007) Expansion of CD56bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-b. Neurol Sci 28:121-126
90. Screpanti V, Wallin R, Grandien A, Ljunggren H (2005) Impact of FASL-induced apoptosis in the elimination of tumor cells. Mol Immunol 42:495-499
91. Shi F, Van Kaer L (2006) Reciptocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol 6:751-760
92. Shi F, Ljunggren H, Sarventnick N (2001) Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol 22:97-101
93. Shimamura M, Huang YY, Okamoto N, Suzuki N, Yasuoka J, Morita K, et al. (2007) Modulation of Vα19 NKT cell immune responses byα-mannosyl ceramide derivatives consisting of a series of modified sphingosines. Eur J Immunol 37:1836-1844
94. Singh A, Wilson M, Hong S, Olivares-Villagomez D, Du C, Stanic A, et al. (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194:1801-1811
95. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, Wekerle H, Hohlfeld R, Goebels N (2004) Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A 101:2428-2433
96. Smeltz R, Wolf N, Swanborg R (1999) Inhibition of autoimmune T cell response in the DA rat by bone marrow-derived NK cells in vitro: implication for autoimmunity. J Immunol 163:1390-1397
97. Smyth M, Swann J, Cretney E, Zerafa N, Yokoyama W, Hayakawa Y (2005) NKG2D function protects the host from tumor initiation. J Exp Med 202:583-588
98. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747
99. Speak A, Salio M, Nerville D, Fontaine J, Priestman DP, Platt N, Heare T, et al. (2007) Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci U S A 104:5971-5976
100. Stacker S, Springer T (1991) Leukocyte intergrin P150, 95 (CD11c/CD18) function as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J Immunol 146:648-655
101. Steinman L (2001) Multiple sclerosis: a two-stage disease. Nat Immunol 2:762-764
102. Takahashi K, Miyake S, Kondo T, Terao K, Hatakenaka M, Hashimoto S, et al. (2001) Natural killer type 2 bias in remission of multiple sclerosis. J Clin Invest 107:R23-R29
103. Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T (2004) The regulatory role of natural killer cells in multiple sclerosis. Brain 127:1917-1927
104. Takeda K, Hayakawa Y, Smyth M, Kayagaki N, Yamaguchi N, Kakuta S, et al. (2001) Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7:94-100
105. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H (2003) The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21:483-513
106. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, et al. (2003) Selection of evolutionary conserved mucosal-associated invariant T cell by MR1. Nature 422:164-169
107. Treiner E, Duban L, Moura I, Hansen T, Gilfillan S, Lantz O (2005) Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect 7:552-559
108. Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 47:187-193
109. Vranes Z, Poljakovic Z, Marusic M (1989) Natural killer cell number and activity in multiple sclerosis. J Neurol Sci 94:115-123
110. Walker L, Abbas A (2002) Keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2:11-19
111. Warren H, Smyth M (1999) NK cells and apoptosis. Immunol Cell Biol 77:64-75
112. Yamamura T, Sakuishi K, Illés Z, Miyake S (2007) Understanding the behavior of invariant NKT cells in autoimmune disease. J Neuroimmunol 191:8-15
113. Yoshimoto T, Bendelac A, Hu-Li J, Paul W (1995) Defective IgE production by SJL mice is linked to the absence of CD4+ NK1.1+ T cells that promptly produce interleukin 4. Proc Natl Acad Sci U S A 92:11931-11934
114. Yu K, Im J, Molano A, Dutronc Y, Illarionov P, Forestier C, et al. Modulation of CD1d-restrotced NKT cell responses by using N-acyl variants ofα-galactosylceramides. Proc Natl Acad Sci U S A (2005) 102:3383-3388
115. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186:1677-1687